Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Incyte Corp (INCY US)
Watchlist
69
Analysis
Health Care
•
United States
Incyte Corp is a biopharmaceutical company. The Company discovers, develops and commercializes proprietary small molecule drugs, primarily used in oncology.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Pharmaessentia Corp
•
25 Nov 2021 23:29
Pharmaessentia Corp (6446 TT): First In-House Drug Approval in the U.S., More to Follow
Pharmaessentia received FDA approval for its new biologics drug for a rare cancer. This article has analyzed its superiority over the existing...
Tina Banerjee
Follow
624 Views
Share
bullish
•
Abbisko Cayman
•
23 Sep 2021 15:48
Abbisko IPO: A Promising but Longer Term Prognosis
While both core products are at an early stage of development, promising trials, management’s track record and blue-chip backers suggest that the...
Arun George
Follow
433 Views
Share
bearish
•
Thematic (Sector/Industry)
•
22 Aug 2021 09:00
China Healthcare Weekly (Aug.20)
The article analyzed the logic change due to the centralized procurement on chemiluminescence products, new regulation about long-term...
Xinyao (Criss) Wang
Follow
265 Views
Share
bullish
•
S&P 500 INDEX
•
22 Jul 2020 21:34
U.S. Equity Strategy: Bullish Outlook Intact
With the S&P 500 breaking above the June highs and the Russell 2000 bullishly inflecting topside a ~1-month base, it signals a continuation of...
Vermilion Research
Follow
409 Views
Share
bullish
•
S&P 500 INDEX
•
28 Nov 2019 06:30
U.S. Equity Strategy: Upgrading Health Care to Overweight
Ongoing bullish developments continue to support our belief that we are in the early stages of a broad-based advance following a nearly 2-year...
Vermilion Research
Follow
394 Views
Share
First
Previous
4
5
6
7
8
9
10
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.49.0
x